about
Efficient inhibition of miR-155 function in vivo by peptide nucleic acidsInhibition of the B cell by CD22: a requirement for LynRegulatory T cells and control of the germinal centre responseMT-HESS: an efficient Bayesian approach for simultaneous association detection in OMICS datasets, with application to eQTL mapping in multiple tissuesAugmentin-induced jaundice with a fatal outcomeThe immunopathology of ANCA-associated vasculitisThe contribution of genetic variation and infection to the pathogenesis of ANCA-associated systemic vasculitisLeucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseasesImmune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodesComparison of gene expression microarray data with count-based RNA measurements informs microarray interpretation.FcγRIIB and autoimmunity.FAS is highly expressed in the germinal center but is not required for regulation of the B-cell response to antigenReceptor modulators of B-cell receptor signalling--CD19/CD22.A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes.A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytesThe generation and maintenance of serum alloantibody.Human T-follicular helper and T-follicular regulatory cell maintenance is independent of germinal centersEmerging concepts in the pathogenesis of antineutrophil cytoplasmic antibody-associated vasculitis.Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection.CD28 expression is required after T cell priming for helper T cell responses and protective immunity to infection.Modules, networks and systems medicine for understanding disease and aiding diagnosis.FcγRIIb inhibits immune complex-induced VEGF-A production and intranodal lymphangiogenesisA multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.B cell inhibitory receptors and autoimmunity.Siglec-G deficiency leads to more severe collagen-induced arthritis and earlier onset of lupus-like symptoms in MRL/lpr mice.Foxp3+ follicular regulatory T cells control the germinal center response.Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease.Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria.CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease.Insight into Genotype-Phenotype Associations through eQTL Mapping in Multiple Cell Types in Health and Immune-Mediated DiseaseT-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection.Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and Fc gamma RII-mediated B cell suppression.bcl-2 transgene expression inhibits apoptosis in the germinal center and reveals differences in the selection of memory B cells and bone marrow antibody-forming cellsFcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis.Analysis of a wild mouse promoter variant reveals a novel role for FcγRIIb in the control of the germinal center and autoimmunity.Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis.B cells in glomerulonephritis: focus on lupus nephritis.Differential signal transduction, membrane trafficking, and immune effector functions mediated by FcgammaRI versus FcgammaRIIaTargeted genomic analysis reveals widespread autoimmune disease association with regulatory variants in the TNF superfamily cytokine signalling network.Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway.
P50
Q24603017-AD648E45-3551-45C9-917F-72F9858B1414Q24647368-8040C665-C543-4ED8-AE01-D090643B48F9Q26829573-F93E20B8-D606-4757-B4AD-8CF108F49C7CQ27304417-66530E84-3F60-4CF7-96F1-06B7AFA28627Q28324594-2EF240F3-E486-4002-83B2-8054BDF67A50Q28391531-558D683D-9C01-4750-BA1C-16850B037031Q28395851-20A10A8E-7F22-4AA8-B16E-29E0F4AC382DQ28602250-945A47AC-C4D6-4046-8D34-9DC808E15871Q30612568-88FE16F5-96F2-4908-85EA-218BD2E902CFQ30840618-4B5A8C6A-69D7-4F50-A348-137FC51EDE0FQ30981881-1B65FA8C-590C-4A4A-9A81-02A079418D67Q33711133-184A756C-5CB2-4A8B-BEA6-FF15872F381AQ33758645-D12F7289-A8EC-4669-83A5-AB3AF8185820Q33789317-EAEDA141-AD0C-476D-A8EE-462400C8B4A7Q33888184-47E14CE5-E1EC-465A-9894-C392C4AA00DDQ34106158-A4B19B1B-B7D0-499F-AA2C-DA35D3C3FF19Q34398374-44CC7E87-172C-413E-87F8-A81B09AF925BQ34460115-45749892-D9E8-4080-A1AA-AD8B5DE071B1Q34518791-4CEBA810-5EA1-4C04-82F8-5CB11D62BCE5Q34561705-7606F586-ED6A-4206-A5C5-4D63015FB7B9Q34624769-09E5F13C-547A-42B6-BD6C-935750F8BBC3Q34752151-038CB354-2E98-4A80-80C7-5550B5B9D02AQ34989833-127F9ACF-9987-4981-8763-D88A7D34F20BQ35072229-8CF63D49-1055-428F-B8E8-63F77A486C24Q35112205-6D0373A3-E754-4130-8E4B-23F3C7EB336CQ35239023-26D827D6-5F6B-47B8-B136-073A731A8D8FQ35310520-00C637EA-EE30-474A-885E-4E8CA53C7572Q35758478-90336C77-0681-4022-8B2F-E1B9490A1C3DQ35909505-3B14FC75-829E-49E9-881E-F339DD84242DQ35970569-90FF25BF-7F7C-4AA6-8CF7-BBFB508ECA91Q36215165-7C595E7A-EB1D-4484-BAC0-2302DFA4F694Q36370119-FCC33A93-4542-4707-919E-CB097F8949D8Q36375912-31B84090-9EBF-4609-AEC1-7911646BD1D3Q36403918-B3496F49-E79B-4A13-8180-58E25CA5777EQ36409027-9B429D1F-3D22-4630-AB61-87F7FAA29BF9Q36910474-265D7C9E-660D-4BDA-A4E1-7AE460990DFEQ36974300-D0BEC4F4-4F68-4999-A71D-542C259F7118Q37078202-C430CB2D-C309-47F6-9A0A-F8F4D0766FBBQ37111489-C67E005D-9162-49B7-A028-9A07495AE7DEQ37215023-D9F0C331-BFD9-4D1A-8958-38592EF80876
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
K G Smith
@ast
K G Smith
@en
K G Smith
@es
K G Smith
@nl
K G Smith
@sl
type
label
K G Smith
@ast
K G Smith
@en
K G Smith
@es
K G Smith
@nl
K G Smith
@sl
altLabel
Ken
@en
prefLabel
K G Smith
@ast
K G Smith
@en
K G Smith
@es
K G Smith
@nl
K G Smith
@sl
P106
P31
P496
0000-0003-3829-4326